Calendar IRLAB Therapeutics AB

Equities

IRLAB A

SE0012675361

Delayed Nasdaq Stockholm 03:55:29 03/05/2024 pm IST 5-day change 1st Jan Change
10.8 SEK -3.14% Intraday chart for IRLAB Therapeutics AB -6.09% +44.00%

Chart calendar IRLAB Therapeutics AB

b1265d4e6ee282b1aa7acd7fc.2GgkYn-uoY1rT_2VBscZ_fP3GStTwZZ8kcEUQl1KAdk.nBleGDL0lOkEIqn2c6FIpIrFLV4G7MAtp7laC3AZZau0LBw7K5vj6EZ6sA~52515e606326a9a713c0402855c04a95

Upcoming events on IRLAB Therapeutics AB

08/05/2024 10:30 am Q1 2024 Earnings Release
22/05/2024 Annual General Meeting
10/07/2024 10:30 am Q2 2024 Earnings Release
25/10/2024 10:30 am Q3 2024 Earnings Release
25/10/2024 01:30 pm Q3 2024 Earnings Call
14/02/2025 11:30 am Q4 2024 Earnings Release
07/05/2025 Q1 2025 Earnings Release (Projected)
27/08/2025 Q2 2025 Earnings Release (Projected)
05/11/2025 Q3 2025 Earnings Release (Projected)
25/02/2026 Q4 2025 Earnings Release (Projected)

Past events on IRLAB Therapeutics AB

18/04/2024 10:15 pm Redeye Investor Forum
07/03/2024 Bayes@Lund Conference
05/03/2024 Alzheimer and Parkinson Diseases International Conference
07/02/2024 02:30 pm Q4 2023 Earnings Call
07/02/2024 11:30 am Q4 2023 Earnings Release
23/11/2023 06:30 pm SEB Healthcare Seminar
23/11/2023 02:30 pm Redeye Life Science Day
22/11/2023 ABGSC Investor Day
26/10/2023 BioStock Life Science Fall Summit
25/10/2023 01:30 pm Q3 2023 Earnings Call
25/10/2023 10:30 am Q3 2023 Earnings Release
25/10/2023 BioStock Life Science Fall Summit
17/10/2023 06:00 pm Capital Markets Day
11/10/2023 01:40 pm Redeye Neurology Theme Forum
14/09/2023 07:20 pm Pareto Securities' Healthcare Conference
30/08/2023 01:30 pm Q2 2023 Earnings Call
30/08/2023 10:30 am Q2 2023 Earnings Release
30/08/2023 ABGSC Investor Day
27/08/2023 MDS Congress
22/08/2023 01:30 pm Mesdopetam Phase IIb and Phase III Study Results Call

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022 2023
Net sales
Million SEK
Released
Forecast
Spread
0,20


0,03
0,00
-
0,00


208
206
1.05%
61,1
44,0
38.95%
5,68
7,10
-20.03%
EBITDA
Million SEK
Released
Forecast
Spread
0,00


-92,9
-84,0
-10.62%
0,00


56,1
62,0
-9.63%
-108
-200
45.83%
-176
-183
3.33%
EBIT
Million SEK
Released
Forecast
Spread
0,00


-95,8
-86,0
-11.45%
0,00


52,6
58,7
-10.39%
-113
-204
44.55%
-181
-185
2.09%
Earnings before Tax (EBT)
Million SEK
Released
Forecast
Spread
0,00


-96,1
-86,0
-11.77%
0,00


51,8
58,2
-11.07%
-113
-204
44.41%
-178
-184
3.09%
Net income
Million SEK
Released
Forecast
Spread
0,00


-96,1
-86,0
-11.77%
-91,7


51,8
58,2
-11.07%
-113
-204
44.41%
-178
-183
3.08%
EPS
SEK
Released
Forecast
Spread
0,00


-2,37
-1,77
-33.9%
-1,92


1,00
1,13
-11.5%
-2,19
-3,85
43.12%
-3,43
-3,55
3.38%
Announcement Date27/02/1906/02/2015/04/2123/02/2223/02/2307/02/24

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4
Net sales
Million SEK
Released
Forecast
Spread
9,04
11,0
-17.8%
23,4
11,0
112.82%
16,5
11,0
50.03%

11,0

EBITDA
Million SEK
Released
Forecast
Spread
-28,1
-33,0
14.72%
-26,1
-45,0
42.1%
-22,9
-55,0
58.34%

-66,0

EBIT
Million SEK
Released
Forecast
Spread
-29,1
-34,0
14.45%
-27,0
-46,0
41.27%
-23,9
-56,0
57.28%

-67,0

Earnings before Tax (EBT)
Million SEK
Released
Forecast
Spread
-29,2
-34,0
14.21%
-27,1
-46,0
41.05%
-24,0
-56,0
57.22%

-67,0

Net income
Million SEK
Released
Forecast
Spread
-29,2
-34,0
14.21%
-27,1
-46,0
41.05%
-24,0
-56,0
57.22%

-67,0

EPS
SEK
Released
Forecast
Spread
-0,56
-0,65
13.85%
-0,52
-0,90
42.22%
-0,46
-1,09
57.8%

-1,19

Announcement Date11/05/2224/08/2209/11/22-

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. IRLAB A Stock
  4. Calendar IRLAB Therapeutics AB